ACTRN12616001073493Completed未知
Randomised controlled trial of an integrated securement device (ISD) or tissue adhesive (TA) versus standard care (bordered polyurethane) dressings on intravascular catheter failure in paediatric patients
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Griffith University
- Enrollment
- 330
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Prevention
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- o limit to 18 Years (—)
- Sex
- All
Inclusion Criteria
- •1. Informed written consent
- •2. PVC in situ
- •3. PVC scheduled/expected use >24 hours
- •4. Patient aged 18 years or less.
- •5, Patient admitted to a Medical, Cardiac or Surgical ward
Exclusion Criteria
- •1. Known, current bloodstream infection (within 48 hours)
- •2. Non-English speakers without interpreter
- •3. PVCs inserted through diseased, burned or scarred skin
- •4. Other types of vascular access devices
- •5. Current skin tear/‘papery’ skin at high risk of tear
- •6. Known allergy to any study product
- •7. Previous enrolment in the current study
Investigators
Similar Trials
Completed
Not Applicable
Secure My Intravascular Line Effectively (SMILE): a pilot randomised controlled trial to evaluate an integrated securement device for peripheral intravenous catheters in medical and surgical patients.Intravenous device failure prior to completion of therapyPublic Health - Health service researchInfection - Other infectious diseasesACTRN12616000984493Griffith University300
Completed
Phase 1
A Healthy APproach to weIght management and Food in Eating Disorders (HAPIFED)Mental Health - Eating disordersBinge eatingDiet and Nutrition - ObesityObesityACTRN12613001209785niversity of Western Sydney33
Recruiting
Phase 4
Trial to study the effects of two iron preparations in patients with iron deficiency anaemia (IDA)CTRI/2011/10/002097none200
Not yet recruiting
Phase 1
A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR20000029591. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Completed
Not Applicable
Topical cyclosporine 2% for herpetic interstitial keratitisHerpetic interstitial keratitis.Herpesviral keratitis and keratoconjunctivitisIRCT2015052112724N2Vice chancellor for research, Isfahan University of Medical Sciences48
